Over the past decade, the metabolic syndrome has
increased dramatically in the population and its
contribution to the development of cardiovascular
disease has grown in parallel. This is an ongoing
situation, and as a consequence, metabolic
abnormalities encompassed by the metabolic syndrome,
such as dyslipidemia, obesity and insulin
resistance, constitute a major threat to public
health. Although the metabolic syndrome has its
limitations as a clinical diagnosis, there is a need
to improve our understanding of its aetiological
link to cardiovascular disease in order to identify...